IP Verse

An Nk 1/Nk 3 Receptor Antagonist For The Treatment Of Sex Hormone Dependent Diseases - EP3574907

PATENT ANALYSIS

Patent Details

Grant Date
Aug 23, 2023
Company
KANDY THERAPEUTICS LIMITED
Oppositions

AERA A/S

More patents of Kandy Therapeutics Limited

EP3574907

Want to monitor this patent?

Feel free to send us a message here and we will get back to you